The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.
More Stories
Top 3 Ethereum rivals gunning for the second-largest crypto spot
As Ethereum continues to dominate the cryptocurrency market as the second-largest digital asset by market capitalization, new contenders like Solana,...
Boeing machinists on picket lines prepare for lengthy strike: ‘I can last as long as it takes’
More than 30,000 Boeing machinists walked off the job Sept. 13. At a local union office outside Seattle, they prepared...
Ethereum Foundation sells 300 ETH as price hits $2.5k
The Ethereum Foundation has sold a total of 950 ETH worth over $2.2 million in the past three weeks On...
Boeing’s defense unit chief Colbert is departing, CEO says
CEO Kelly Ortberg said a replacement for Ted Colbert would be named later.
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's...
Family offices are the most bullish they’ve been in years, survey says
Nearly half of family offices are expecting double-digit returns this year, according to Citi Private Bank's 2024 Global Family Office...